Clinical trial Recruiting at 1 site Interventional Ages 1 Month to 11

Evaluating the impact of discharging premature newborns weighing less than 2 kilos

Official title: Assessment of the Impact of the Return Home of Premature Newborns With Intrauterine Growth Retardation Weighing Less Than 2 Kilos (Low Birth Weight) on Short- and Long-term Morbidity/Mortality

Run by Hôpital NOVO · NCT06224764 · Data updated 2026-11-12

This study looks at how discharging premature newborns who weigh less than 2 kilos affects their health and survival, by gathering feedback from parents about their experiences.

More Premature Birth trials

Quick facts

Study typeInterventional
Ages1 Month to 11 Years
SexAll
Enrollment40 (estimated)
SponsorHôpital NOVO
Academic / other
Locations1 site (Pontoise)
StatusRecruiting
StartedFebruary 21, 2024
Main results expectedNovember 2025
Study endsNovember 2025
Registry record updatedJanuary 3, 2025
Trial IDNCT06224764 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are premature newborns born at less than 37 weeks of gestation who weigh less than 2 kg at discharge.

Probably not a fit

Patients who are transferred to another hospital before discharge or whose parents do not speak or understand French may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess the short-term and long-term outcomes of premature newborns who weigh less than 2 kilos at the time of discharge from the neonatology department at Hôpital NOVO. It will involve collecting data through questionnaires from parents to understand the effects of early discharge on morbidity and mortality rates. The research focuses on the implications of current discharge criteria and the role of parental involvement and health worker support in the care of these vulnerable infants. The study will analyze data from newborns discharged between 2012 and 2024 to provide insights into the effectiveness of these practices.

Why it matters

Potential benefit: If successful, this study could lead to improved discharge protocols for premature infants, potentially reducing morbidity and mortality rates.

How similar studies have gone: Other studies have shown success in evaluating discharge criteria for premature infants, indicating that this approach is supported by existing research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Premature newborn baby (born at less than 37 days' gestation)
* Newborn baby with IUGR (Intra-Uterine Growth Retardation)
* Newborn baby hospitalised in the neonatology department of the NOVO hospital - Pontoise site
* Patient born between 01/01/2012 and 31/12/2024.
* Newborn who has left the neonatology department or the Kangaroo Unit to return home weighing less than 2 kg.
* Newborn beneficiary of a social security scheme or entitled person.

Exclusion Criteria:

* Newborn transferred to another hospital before discharge.
* Refusal by one of the parents.
* Parent does not speak or understand French.

Where it's running

  • Resuscitation and neonatal medicine department - Hôpital NOVO - Pontoise site
    Pontoise, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.